Riskpilot← Back to searchSign inGet full accessProTreatment Invest ApS
APSActiveCVR 36018461A.P. Møllers Allé 43CRental and operating of own or leased real estate · NACE 6820Est. 2014— employees
Revenue 2024
DKK 3,2M
-15% vs 2023
EBITDA margin
100.0%
-15% vs 2023
Equity ratio
3.4%
Financial strength
Net profit 2024
DKK -240K
-140% vs 2023
| Revenue | DKK 3,2M | -15% |
| EBITDA | DKK 3,2M | -15% |
| Net profit | DKK -240K | -140% |
| Total assets | DKK 65,3M | +11% |
| Equity | DKK 2,2M | -10% |
| Employees | — | — |
Legal name
ProTreatment Invest ApS
CVR number
36018461
Legal form
Anpartsselskab
NACE code
6820 · Rental and operating of own or leased real estate
Founded
24. juni 2014
Share capital
DKK 50.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller af den samlede direktion.
Company purpose
Selskabets formål er at eje fast ejendom og hermed ligestillet virksomhed
Address
A.P. Møllers Allé 43C
Email
invest@protreatment.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 427 | 505 | 1.377 | 1.211 | 827 | 1.647 | 2.901 | 3.129 | 3.789 | 3.231 |
| Staff expenses | -0 | -0 | -0 | -0 | -7 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 43 | 427 | 505 | 1.377 | 1.204 | 827 | 1.647 | 2.901 | 3.129 | 3.789 | 3.231 |
| Depreciation & amort. | -0 | -48 | -110 | -366 | -366 | -375 | -465 | -659 | -893 | -1.040 | -1.187 |
| EBIT | 43 | 379 | 395 | 1.011 | 838 | 452 | 1.183 | 2.242 | 2.237 | 2.749 | 2.044 |
| Net financials | -90 | -177 | -513 | -870 | -740 | -681 | -841 | -862 | -1.109 | -1.823 | -2.087 |
| Profit before tax | -47 | 202 | -119 | 141 | 97 | -229 | 342 | 1.380 | 1.127 | 926 | -43 |
| Tax | -12 | 49 | -26 | 31 | 48 | -65 | 77 | 320 | 643 | 320 | 197 |
| Net profit | -35 | 153 | -92 | 110 | 49 | -164 | 265 | 1.060 | 484 | 607 | -240 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.994 | 5.191 | 24.070 | 24.564 | 24.276 | 23.890 | 38.678 | 47.606 | 52.854 | 58.674 | 65.307 |
| Equity | 15 | 168 | 75 | 185 | 236 | 72 | 337 | 1.398 | 1.882 | 2.489 | 2.249 |
| Long-term debt | 4.801 | 4.396 | 6.948 | 22.568 | 22.654 | 21.172 | 34.095 | 32.969 | 44.297 | 37.282 | 44.598 |
| Short-term debt | 178 | 626 | 17.047 | 1.811 | 1.365 | 2.629 | 4.209 | 13.211 | 6.295 | 18.495 | 17.984 |
| Total debt | 4.979 | 5.023 | 23.995 | 24.379 | 24.020 | 23.800 | 38.304 | 46.180 | 50.593 | 55.777 | 62.582 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20142024
Equity ratio
3.4%
This company
38.2%
Market median
-91% vs market
20142024
Return on equity
-10.7%
This company
18.4%
Market median
-158% vs market
20142024
Net profit margin
-7.4%
This company
8.1%
Market median
-191% vs market
20142024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20142024
Debt / equity
28.04×
This company
0.62×
Market median
-4423% vs market
20142024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-06-24 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NS Management | Management | 2018 | — | — |
TJ Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ProTreatment Holding ApS | Company | 100.0% | 100.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ProTreatment Holding ApS
ProTreatment Invest ApS Board members of ProTreatment Invest ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nadia Seistrup | Management | 0 companies |
| Thomas Jørgensen | Chief Executive Officer | 0 companies |